Immunosuppressive regimens in lung transplant recipients

Sangeeta M. Bhorade; Jaime Villanueva; Ashby Jordan; Edward R. Garrity

doi:10.1358/dot.2004.40.12.872575

Immunosuppressive regimens in lung transplant recipients

Sangeeta M. Bhorade^*, Jaime Villanueva, Ashby Jordan, Edward R. Garrity

^*Corresponding author for this work

Medicine, Pulmonary Division

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Abstract

A lung transplant is usually the last resort treatment for lung failure. Since the introduction of cyclosporine A, success rates after solid organ transplantation began to rise, following an incremental curve over the last decade, in which further development of biological agents and newer immunosuppressive agents has continued to improve outcomes after transplantation. Pharmacokinetic and pharmacodynamic properties, as well as efficacy and safety data from clinical trials with immunosuppressive agents and biological agents currently available, are reviewed here.

Original language	English (US)
Pages (from-to)	1003-1012
Number of pages	10
Journal	Drugs of Today
Volume	40
Issue number	12
DOIs	https://doi.org/10.1358/dot.2004.40.12.872575
State	Published - Dec 1 2004

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Access to Document

10.1358/dot.2004.40.12.872575

Fingerprint Dive into the research topics of 'Immunosuppressive regimens in lung transplant recipients'. Together they form a unique fingerprint.

Cite this

@article{c311cadef36b472c8fe3b35f9e6fb11e,

title = "Immunosuppressive regimens in lung transplant recipients",

abstract = "A lung transplant is usually the last resort treatment for lung failure. Since the introduction of cyclosporine A, success rates after solid organ transplantation began to rise, following an incremental curve over the last decade, in which further development of biological agents and newer immunosuppressive agents has continued to improve outcomes after transplantation. Pharmacokinetic and pharmacodynamic properties, as well as efficacy and safety data from clinical trials with immunosuppressive agents and biological agents currently available, are reviewed here.",

author = "Bhorade, {Sangeeta M.} and Jaime Villanueva and Ashby Jordan and Garrity, {Edward R.}",

year = "2004",

month = dec,

day = "1",

doi = "10.1358/dot.2004.40.12.872575",

language = "English (US)",

volume = "40",

pages = "1003--1012",

journal = "Drugs of Today",

issn = "1699-3993",

publisher = "Prous Science",

number = "12",

}

TY - JOUR

T1 - Immunosuppressive regimens in lung transplant recipients

AU - Bhorade, Sangeeta M.

AU - Villanueva, Jaime

AU - Jordan, Ashby

AU - Garrity, Edward R.

PY - 2004/12/1

Y1 - 2004/12/1

N2 - A lung transplant is usually the last resort treatment for lung failure. Since the introduction of cyclosporine A, success rates after solid organ transplantation began to rise, following an incremental curve over the last decade, in which further development of biological agents and newer immunosuppressive agents has continued to improve outcomes after transplantation. Pharmacokinetic and pharmacodynamic properties, as well as efficacy and safety data from clinical trials with immunosuppressive agents and biological agents currently available, are reviewed here.

AB - A lung transplant is usually the last resort treatment for lung failure. Since the introduction of cyclosporine A, success rates after solid organ transplantation began to rise, following an incremental curve over the last decade, in which further development of biological agents and newer immunosuppressive agents has continued to improve outcomes after transplantation. Pharmacokinetic and pharmacodynamic properties, as well as efficacy and safety data from clinical trials with immunosuppressive agents and biological agents currently available, are reviewed here.

UR - http://www.scopus.com/inward/record.url?scp=12344299578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12344299578&partnerID=8YFLogxK

U2 - 10.1358/dot.2004.40.12.872575

DO - 10.1358/dot.2004.40.12.872575

M3 - Review article

C2 - 15645011

AN - SCOPUS:12344299578

VL - 40

SP - 1003

EP - 1012

JO - Drugs of Today

JF - Drugs of Today

SN - 1699-3993

IS - 12

ER -

Immunosuppressive regimens in lung transplant recipients

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this